Telementoring for Diabetes Care Improvement
What You Need to Know Before You Apply
What is the purpose of this trial?
Diabetes care is complex and requires a multidimensional approach, but interventional programs are difficult to initiate in low-income and minority populations. In the proposed study, investigators will mentor local clinics via telehealth to initiate our diabetes program involving telehealth-support, integrated CHWs, medication-access, and diabetes Education into their clinics. Mentoring local clinics to initiate this intervention is a promising strategy to enhance sustainable diabetes care and reduce disparities in vulnerable minority populations.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems likely that you can continue your current diabetes medications, as the trial involves mentoring clinics to improve diabetes care.
Is telementoring generally safe for humans?
How is the telementoring treatment for diabetes care unique?
Telementoring for diabetes care is unique because it uses the Project ECHO model to connect primary care providers with specialists, allowing them to gain expertise in managing complex diabetes cases. This approach helps improve care in underserved areas by sharing specialist knowledge with multiple providers, unlike traditional telemedicine that typically connects one patient with a specialist.13567
What data supports the effectiveness of the treatment Telementoring for diabetes care improvement?
Research shows that the telementoring model, like Project ECHO, helps improve diabetes management in underserved communities by enhancing the knowledge and skills of healthcare providers. This approach has been effective in managing complex diabetes cases and improving health outcomes, especially in areas with limited access to specialists.13567
Who Is on the Research Team?
Elizabeth Vaughan, DO
Principal Investigator
UTMB
Are You a Good Fit for This Trial?
This trial is for Spanish-speaking adults over 18 with type 2 diabetes, an HbA1c level of at least 6.5%, and taking oral diabetes medication. Participants must be uninsured, below the poverty line, and self-identify as Latino(a). It's not for those who miss group visits, have conditions affecting HbA1c levels or need frequent clinic visits.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive a 12-month diabetes program involving telehealth support, integrated CHWs, medication access, and diabetes education
Follow-up
Participants are monitored for clinical changes including HbA1c, blood pressure, cholesterol, and BMI
What Are the Treatments Tested in This Trial?
Interventions
- Telementoring
Find a Clinic Near You
Who Is Running the Clinical Trial?
The University of Texas Medical Branch, Galveston
Lead Sponsor
Baylor College of Medicine
Collaborator
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator
University of Texas
Collaborator
The University of Texas Health Science Center, Houston
Collaborator
University of Houston
Collaborator